HMO Market is Projected to Reach $556 million by 2027

The global HMO market is estimated to be valued at USD 199 million in 2022. It is projected to reach USD 556 million by 2027, recording a CAGR of 22.7% during the forecast period.

The global HMO market has been influenced by some of the macroeconomic and microeconomic factors witnessed in some key countries. This would prove strong enough to drive the market significantly in terms of value sales during the forecast period. With the rise in number of infants across the globe, the demand and preference for HMO-based infant formula along with the trend of adopting healthy lifestyle by consuming functional food and beverages has significantly boosted the utilization of HMO in manufacturing.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=220134357

Drivers: Rise in infant population

The UN data suggests that over 250 babies are born per minute globally. An average of 353,000 babies are born per day, making the total count of babies born in a year more than 130 million. This directly results in the rise in the consumption of infant formulas at a global level. Several other factors are also responsible for this increased consumption. Some of these include a rise in the number of working women post-giving birth, the inability of mothers to lactate, and better nutrition options for growing infants. According to the UN, the global population is projected to reach 9.6 billion by 2050. Human milk oligosaccharides are used as a major ingredient in the infant nutrition industry for manufacturing various infant formula and baby food. This constantly expanding population is expected to boost the sales of human milk oligosaccharides as an infant formula ingredient in the coming years. According to the National Bureau of Statistics of China, the country recorded 15.23 million births in 2018, creating a lucrative opportunity for manufacturers. Thus, China is expected to be a key revenue generator for the human milk oligosaccharides market.

Opportunities: Emergence of alternative animal milk oligosaccharides

Bovine milk oligosaccharides are expected to play a key role in infant nutrition. A laboratory study by RMIT University (Australia), published in the British Journal of Nutrition, suggested that goat milk infant formula had similar prebiotic properties to breast milk and is expected to play a key role in the gut health of infants. Ausnutria Nutrition BV (Netherlands) offers goat milk-based infant formulas under its brand, Kabrita.

Another animal source is camel milk. In 2018, a UAE-based company, the Emirates Industry for Camel Milk and Products, also known as 'Camelicious,' launched a camel milk-based baby formula containing a high amount of iron for babies aged 1-3 years. Thus, these sources of animal milk oligosaccharides are expected to gain acceptance in the infant formula ingredients markets in the coming years. rigorous regulatory requirements in the environmental protection sector apply to the manufacturers' production processes and their production environment

Challenges: Complex industrial process to extract oligosaccharides from milk

One of the biggest challenges associated with developing large-scale or industrial processes to recover oligosaccharides from mammalian milk is achieving a high degree of purity. More specifically, the challenge is to remove simple sugars such as lactose, glucose, and galactose that lack prebiotic activities and might have adverse effects while simultaneously maximizing product recovery. The use of lactose hydrolysis combined with membrane filtration to recover oligosaccharides from milk was successful; however, as the process remains tedious, there is a need to introduce much more advanced and convenient techniques through rigorous techniques research and development activities.

Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=220134357

Asia Pacific is projected to reach USD 321.8 million during the forecast period.

In 2021, Asia Pacific accounted for a market share of 58.8% in the global HMO market. The Asia Pacific market is completely driven by the country markets of China, India, Japan, Australia & New Zealand and few other Asian countries such as Taiwan, Thailand etc. The regional market of HMO in Asia Pacific has witnessed technological advancement brought by the key market players, which has increased its usage in various industries. Being a densely populated region, the countries in Asia Pacific such as China, India etc. experiences a continuous rise in demand for food and nutrition products. The use of HMO across different industries such as infant formula, functional food and beverages, food supplements in manufacturing a range of infant food, baby food etc. is anticipated to drive the market during the forecast period. Further developments introduced by the key market players in offering advanced and convenient products to the global consumer is expected to drive the market.

The key players in this market include DSM (Netherlands), BASF SE (Germany), Chr. Hansen Holding A/S (Denmark), DUPONT ( US), and Royal FrieslandCampina N.V. (Netherlands).

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.